Cerebriu is revolutionizing MRI scans for brain tumors, hemorrhages, and strokes with groundbreaking AI software. While the patient is still in the scanner, the AI analyzes data in real-time, providing instant clarification, which greatly benefits both patients and healthcare professionals by enabling quicker and more accurate diagnoses. After a brief recap of this innovative product and its market, Robert Lauritzen, CEO of Cerebriu, will delve into what is fundamental for deep tech companies like Cerebriu to succeed. He will share some highlights from the Cerebriu journey, focusing on the critical aspects of the team and financing that have supported their progress.